PetVivo Holdings, Inc. (OTCQX: PETV; OTC ID: PETVW), through its wholly owned subsidiary Petvivo Animal Health, a leading biomedical company delivering innovative medical devices and therapeutics for ...
Cost of revenues for the nine months ended September 30, 2025 totaled $7.9 million compared to $11.4 million in the same period last year. The decrease was primarily due to a decrease in jet card and ...
In both fatal cases, patients developed markedly elevated liver enzymes and required hospitalization within two months of Elevidys infusion. An additional serious, non-fatal case of acute liver injury ...
Leading CIOs honored for leadership, innovation, and business impact. NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results